NSGENE A/S: Financial statements 2012
CVR: 21479195
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NSGENE A/S (CVR 21479195) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 8,819,000 and a net result of DKK -3,700,000. The profit margin was -42%. Equity in the 2012 report amounted to DKK -15,202,000.
- Revenue
- DKK 8,819,000
- Gross Profit
- DKK 4,557,000
- Profit/Loss
- DKK -3,700,000
- Equity
- DKK -15,202,000
- Total Assets
- DKK 27,187,000
Official annual report
Keep an eye on NSGENE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 30, 2012, Ingelise Saunders has joined the board of directors of NSGENE A/S.
As of April 30, 2012, Gudmund Tyge Korsgaard has joined the board of directors of NSGENE A/S.
As of April 30, 2012, Finn Eggert Sørensen has joined the board of directors of NSGENE A/S.
As of April 30, 2012, Elsebeth Budolfsen has left the board of directors of NSGENE A/S.
As of April 30, 2012, Martin Olin has left the board of directors of NSGENE A/S.
As of April 30, 2012, Finn Eggert Sørensen has left the board of directors of NSGENE A/S.
As of April 30, 2012, René Schneider is registered as chairman of NSGENE A/S.
As of April 30, 2012, Jørgen Drejer has stepped down as vice chairman of NSGENE A/S.
As of April 30, 2012, Mats Gunnar Pettersson has stepped down as chairman of NSGENE A/S.
About NSGENE A/S
NSGENE A/S was a Danish company of the type Aktieselskab based in Ballerup, founded in 1999. The company has been dissolved on 1 May 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named A/S PSE NR. 5423. The company has 0 employees (2017). In 2015, the company reported revenue of DKK 11,986,000 and a net result of DKK 10,798,000 compared with DKK 9,315,000 the year before. Equity in the 2015 report amounted to DKK 9,761,000.